CoChat

Current AI technologies in cancer diagnostics and treatment

Open access
Tiwari, Ashutosh, Mishra, Soumya, Kuo, Tsung-Rong · 2025 · Molecular Cancer
Cited by 207

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Cancer continues to be a significant international health issue, which demands the invention of new methods for early detection, precise diagnoses, and personalized treatments. Artificial intelligence (AI) has rapidly become a groundbreaking component in the modern era of oncology, offering sophisticated tools across the range of cancer care. In this review, we performed a systematic survey of the current status of AI technologies used for cancer diagnoses and therapeutic approaches. We discuss AI-facilitated imaging diagnostics using a range of modalities such as computed tomography, magnetic resonance imaging, positron emission tomography, ultrasound, and digital pathology, highlighting the growing role of deep learning in detecting early-stage cancers. We also explore applications of AI in genomics and biomarker discovery, liquid biopsies, and non-invasive diagnoses. In therapeutic interventions, AI-based clinical decision support systems, individualized treatment planning, and AI-facilitated drug discovery are transforming precision cancer therapies. The review also evaluates the effects of AI on radiation therapy, robotic surgery, and patient management, including survival predictions, remote monitoring, and AI-facilitated clinical trials. Finally, we discuss important challenges such as data privacy, interpretability, and regulatory issues, and recommend future directions that involve the use of federated learning, synthetic biology, and quantum-boosted AI. This review highlights the groundbreaking potential of AI to revolutionize cancer care by making diagnostics, treatments, and patient management more precise, efficient, and personalized. Graphical Abstract This graphical abstract schematically illustrates the progressive role of artificial intelligence in the cancer treatment continuum.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-025-02369-9

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 204

  1. The global challenge of cancer. Nat Cancer. 2020;1:1–2. · DOI
  2. Deep learning - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/26017442/. Cited 2025 Mar 11.
  3. Kehl KL, Xu W, Lepisto E, Elmarakeby H, Hassett MJ, Van Allen EM, et al. Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes. JCO Clin Cancer Inform. 2020;4:680–90. · DOI · Paper page
  4. Wang G, Jung K, Winnenburg R, Shah NH. A method for systematic discovery of adverse drug events from clinical notes. J Am Med Inform Assoc. 2015;22:1196–204. · DOI · Paper page
  5. Haddad T, Helgeson JM, Pomerleau KE, Preininger AM, Roebuck MC, Dankwa-Mullan I, et al. Accuracy of an Artificial Intelligence System for Cancer Clinical Trial Eligibility Screening: Retrospective Pilot Study. JMIR Med Inform. 2021;9: e27767. · DOI · Paper page
  6. Gu J, Wang Z, Kuen J, Ma L, Shahroudy A, Shuai B, et al. Recent Advances in Convolutional Neural Networks. arXiv; 2017. Available from: http://arxiv.org/abs/1512.07108. Cited 2025 Apr 22. · arXiv
  7. Iqbal MJ, Javed Z, Sadia H, Qureshi IA, Irshad A, Ahmed R, et al. Clinical applications of artificial intelligence and machine learning in cancer diagnosis: looking into the future. Cancer Cell Int. 2021;21:270. · DOI · Paper page
  8. Lu J, Lu X, Wang Y, Zhang H, Han L, Zhu B, et al. Comparison between logistic regression and machine learning algorithms on prediction of noise-induced hearing loss and investigation of SNP loci. Sci Rep. 2025;15:15361. · DOI
  9. Shiri FM, Perumal T, Mustapha N, Mohamed R. A Comprehensive Overview and Comparative Analysis on Deep Learning Models: CNN, RNN, LSTM. GRU JAI. 2024;6:301–60. · DOI
  10. Jordan ID, Sokol PA, Park IM. Gated recurrent units viewed through the lens of continuous time dynamical systems. Front Comput Neurosci. 2021;15: 678158. · DOI
  11. Schmidt RM. Recurrent Neural Networks (RNNs): A gentle Introduction and Overview. arXiv; 2019. Available from: http://arxiv.org/abs/1912.05911. Cited 2025 May 24. · arXiv
  12. He K, Zhang X, Ren S, Sun J. Deep Residual Learning for Image Recognition. arXiv; 2015. Available from: http://arxiv.org/abs/1512.03385. Cited 2025 May 24. · arXiv
  13. Dosovitskiy A, Beyer L, Kolesnikov A, Weissenborn D, Zhai X, Unterthiner T, et al. An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale. arXiv; 2021. Available from: http://arxiv.org/abs/2010.11929. Cited 2025 May 24. · arXiv
  14. Ding J, Ma S, Dong L, Zhang X, Huang S, Wang W, et al. LongNet: Scaling Transformers to 1,000,000,000 Tokens. arXiv; 2023. Available from: http://arxiv.org/abs/2307.02486. Cited 2025 May 24. · DOI
  15. Ronneberger O, Fischer P, Brox T. U-Net: Convolutional Networks for Biomedical Image Segmentation. arXiv; 2015. Available from: http://arxiv.org/abs/1505.04597. Cited 2025 May 24. · arXiv
  16. Cosentino R, Balestriero R, Baraniuk R, Aazhang B. Deep Autoencoders: From Understanding to Generalization Guarantees. arXiv; 2021. Available from: http://arxiv.org/abs/2009.09525. Cited 2025 May 24. · arXiv
  17. Goodfellow IJ, Pouget-Abadie J, Mirza M, Xu B, Warde-Farley D, Ozair S, et al. Generative Adversarial Networks. arXiv; 2014. Available from: http://arxiv.org/abs/1406.2661. Cited 2025 May 24. · arXiv
  18. Makhzani A, Shlens J, Jaitly N, Goodfellow I, Frey B. Adversarial Autoencoders. arXiv; 2016. Available from: http://arxiv.org/abs/1511.05644. Cited 2025 May 24. · arXiv
  19. Yu J, Dai Y, Liu X, Huang J, Shen Y, Zhang K, et al. Unleashing the Power of Multi-Task Learning: A Comprehensive Survey Spanning Traditional, Deep, and Pretrained Foundation Model Eras. arXiv; 2024. Available from: http://arxiv.org/abs/2404.18961. Cited 2025 May 25. · arXiv
  20. Chen T, Kornblith S, Norouzi M, Hinton G. A Simple Framework for Contrastive Learning of Visual Representations. arXiv; 2020. Available from: http://arxiv.org/abs/2002.05709. Cited 2025 May 25. · arXiv
  21. Ericsson L, Gouk H, Loy CC, Hospedales TM. Self-Supervised Representation Learning: Introduction, Advances and Challenges. IEEE Signal Process Mag. 2022;39:42–62. · DOI · Paper page
  22. Chen H-Y, Lai Z, Zhang H, Wang X, Eichner M, You K, et al. Contrastive Localized Language-Image Pre-Training. arXiv; 2025. Available from: http://arxiv.org/abs/2410.02746. Cited 2025 May 25. · arXiv
  23. Pei Q, Zhang W, Zhu J, Wu K, Gao K, Wu L, et al. BioT5: Enriching Cross-modal Integration in Biology with Chemical Knowledge and Natural Language Associations. arXiv; 2024. Available from: http://arxiv.org/abs/2310.07276. Cited 2025 May 25. · DOI
  24. OpenAI, Achiam J, Adler S, Agarwal S, Ahmad L, Akkaya I, et al. GPT-4 Technical Report. arXiv; 2024. Available from: http://arxiv.org/abs/2303.08774. Cited 2025 May 25. · arXiv
  25. Ling Y. Bio+Clinical BERT, BERT Base, and CNN Performance Comparison for Predicting Drug-Review Satisfaction. arXiv; 2023. Available from: http://arxiv.org/abs/2308.03782. Cited 2025 May 25. · arXiv
  26. Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, et al. Attention Is All You Need. arXiv; 2023. Available from: http://arxiv.org/abs/1706.03762. Cited 2025 May 25. · arXiv
  27. McMahan HB, Moore E, Ramage D, Hampson S, Arcas BA y. Communication-Efficient Learning of Deep Networks from Decentralized Data. arXiv; 2023. Available from: http://arxiv.org/abs/1602.05629. Cited 2025 May 25. · arXiv
  28. Noman SM, Fadel YM, Henedak MT, Attia NA, Essam M, Elmaasarawii S, et al. Leveraging survival analysis and machine learning for accurate prediction of breast cancer recurrence and metastasis. Sci Rep. 2025;15:3728. · DOI
  29. Tafvizi A, Avci B, Sundararajan M. Attributing AUC-ROC to Analyze Binary Classifier Performance. arXiv; 2022. Available from: http://arxiv.org/abs/2205.11781. Cited 2025 May 25. · arXiv
  30. Mandrekar JN. Simple statistical measures for diagnostic accuracy assessment. J Thorac Oncol. 2010;5:763–4. · DOI
  31. Longato E, Vettoretti M, Di Camillo B. A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models. J Biomed Inform. 2020;108: 103496. · DOI · Paper page
  32. Düntsch I, Gediga G. Confusion matrices and rough set data analysis. J Phys: Conf Ser. 2019;1229: 012055.
  33. Esserman LJ, WISDOM Study and Athena Investigators. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017;3:34. · DOI · Paper page
  34. Maroni R, Massat NJ, Parmar D, Dibden A, Cuzick J, Sasieni PD, et al. A case-control study to evaluate the impact of the breast screening programme on mortality in England. Br J Cancer. 2021;124:736–43. · DOI
  35. Sasieni P. Evaluation of the UK breast screening programmes. Ann Oncol. 2003;14:1206–8. · doi:10.1093/annonc/mdg325
  36. Meystre SM, Heider PM, Kim Y, Aruch DB, Britten CD. Automatic trial eligibility surveillance based on unstructured clinical data. Int J Med Inform. 2019;129:13–9. · DOI
  37. Dembrower K, Wåhlin E, Liu Y, Salim M, Smith K, Lindholm P, et al. Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study. Lancet Digit Health. 2020;2:e468–74. · DOI · Paper page
  38. Z D, Fz F, R H, R M. Artificial intelligence (AI) and big data in cancer and precision oncology. Computational and structural biotechnology journal. 2020;18. Available from: https://pubmed.ncbi.nlm.nih.gov/32994889/?dopt=Abstract. Cited 2025 Mar 11.
  39. Yip SSF, Parmar C, Kim J, Huynh E, Mak RH, Aerts HJWL. Impact of experimental design on PET radiomics in predicting somatic mutation status. Eur J Radiol. 2017;97:8–15. · DOI
  40. Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500–10. · DOI · Paper page
  41. Fu Y, Zhang H, Morris ED, Glide-Hurst CK, Pai S, Traverso A, et al. Artificial Intelligence in Radiation Therapy. IEEE Transactions on Radiation and Plasma Medical Sciences. 2022;6:158–81. · DOI
  42. Xie X, Wang X, Liang Y, Yang J, Wu Y, Li L, et al. Evaluating cancer-related biomarkers based on pathological images: a systematic review. Front Oncol. 2021;11: 763527. · DOI
  43. Bayramoglu N, Kannala J, Heikkila J. Deep learning for magnification independent breast cancer histopathology image classification. 2016. p. 2445. · DOI · Paper page
  44. Schutte K, Brulport F, Harguem-Zayani S, Schiratti J-B, Ghermi R, Jehanno P, et al. An artificial intelligence model predicts the survival of solid tumour patients from imaging and clinical data. Eur J Cancer. 2022;174:90–8. · DOI
  45. Ma Y, Jamdade S, Konduri L, Sailem H. AI in Histopathology Explorer for comprehensive analysis of the evolving AI landscape in histopathology. npj Digital Medicine. 2025;8:156. · DOI
  46. Jiang LY, Liu XC, Nejatian NP, Nasir-Moin M, Wang D, Abidin A, et al. Health system-scale language models are all-purpose prediction engines. Nature. 2023;619:357–62. · DOI · Paper page
  47. Sarkhel^1 D, Pradhan U. Future perspectives on AI in breast cancer detection: A mini review. Journal of Artificial IN℡LIGENCE. 2024;1:1–5. · DOI
  48. John KM, Tenner J, Croocks R, Valente C, Bingham B, Habowski AN, et al. An AI-assisted navigation approach for patients with radiographic suspicion of new pancreas cancer. JCO. 2024;42:11002–11002. · doi:10.1200/jco.2024.42.16_suppl.11002
  49. Wu W, Hu D, Niu C, Yu H, Vardhanabhuti V, Wang G. DRONE: Dual-domain Residual-based Optimization NEtwork for Sparse-view CT Reconstruction. IEEE Trans Med Imaging. 2021;40:3002–14. · DOI · Paper page
  50. Pantanowitz L, Quiroga-Garza GM, Bien L, Heled R, Laifenfeld D, Linhart C, et al. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study. Lancet Digit Health. 2020;2:e407–16. · DOI · Paper page
  51. Eisemann N, Bunk S, Mukama T, Baltus H, Elsner SA, Gomille T, et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. Nat Med. 2025;1–8. · DOI · Paper page
  52. Arthur A, Orton MR, Emsley R, Vit S, Kelly-Morland C, Strauss D, et al. A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis. Lancet Oncol. 2023;24:1277–86. · DOI
  53. Zhou H, Watson M, Bernadt CT, Lin SS, Lin C-Y, Ritter JH, et al. AI-guided histopathology predicts brain metastasis in lung cancer patients. J Pathol. 2024;263:89–98. · DOI
  54. Nikitas J, Gafita A, Benz MR, Djaïleb L, Farolfi A, Hotta M, et al. Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy. Sci Rep. 2024;14:24411. · DOI
  55. Abian AI, Khan Raiaan MA, Karim A, Azam S, Fahad NM, Shafiabady N, et al. Automated diagnosis of respiratory diseases from lung ultrasound videos ensuring XAI: an innovative hybrid model approach. Front Comput Sci. 2024;6. Available from: https://www.frontiersin.org/journals/computer-science/articles/10.3389/fcomp.2024.1438126/full. Cited 2025 Mar 17. · DOI
  56. Zhu M, Li S, Kuang Y, Hill VB, Heimberger AB, Zhai L, et al. Artificial intelligence in the radiomic analysis of glioblastomas: A review, taxonomy, and perspective. Front Oncol. 2022;12: 924245. · DOI
  57. Doori LA, Evanson D, Revheim M-E, Saboury B, Alavi A, Torigian D. Advancements in [18F]FDG-PET/CT Radiomics and Machine Learning for Non-Small Cell Lung Cancer. J Nucl Med. 2024;65:241765–241765.
  58. Spadaccini M, Iannone A, Maselli R, Badalamenti M, Desai M, Chandrasekar VT, et al. Computer-aided detection versus advanced imaging for detection of colorectal neoplasia: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology. 2021;6:793–802. · DOI · Paper page
  59. Lou S, Du F, Song W, Xia Y, Yue X, Yang D, et al. Artificial intelligence for colorectal neoplasia detection during colonoscopy: a systematic review and meta-analysis of randomized clinical trials. eClinicalMedicine. 2023;66. Available from: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00518-7/fulltext. Cited 2025 Mar 17. · DOI
  60. Ludwig M, Ludwig B, Mikuła A, Biernat S, Rudnicki J, Kaliszewski K. The Use of Artificial Intelligence in the Diagnosis and Classification of Thyroid Nodules: An Update. Cancers (Basel). 2023;15:708. · DOI
  61. Feng Y, Wang Y. Comparison of the classifiers based on mRNA, microRNA and lncRNA expression and DNA methylation profiles for the tumor origin detection. Front Genet. 2024;15. Available from: https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2024.1383852/full. Cited 2025 Apr 5. · DOI
  62. Tang W, Duan J, Zhang J-G, Wang Y-P. Subtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approach. EURASIP J Bioinform Syst Biol. 2013;2013:2. · DOI
  63. Choi JM, Chae H. moBRCA-net: a breast cancer subtype classification framework based on multi-omics attention neural networks. BMC Bioinformatics. 2023;24:169. · DOI
  64. Jahangiri L. Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review. Med Sci (Basel). 2024;12:5.
  65. Pidíková P, Herichová I. miRNA Clusters with Up-Regulated Expression in Colorectal Cancer. Cancers (Basel). 2021;13:2979. · DOI
  66. EL-Manzalawy Y, Hsieh T-Y, Shivakumar M, Kim D, Honavar V. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data. BMC Medical Genomics. 2018;11:71. · DOI
  67. Hamedi SZ, Emami H, Khayamzadeh M, Rabiei R, Aria M, Akrami M, et al. Application of machine learning in breast cancer survival prediction using a multimethod approach. Sci Rep. 2024;14:30147. · DOI
  68. Arslan E, Schulz J, Rai K. Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine. Biochim Biophys Acta Rev Cancer. 2021;1876: 188588. · DOI
  69. Sufyan M, Shokat Z, Ashfaq UA. Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective. Comput Biol Med. 2023;165: 107356. · DOI
  70. O’Connor O, McVeigh TP. Increasing use of artificial intelligence in genomic medicine for cancer care- the promise and potential pitfalls. BJC Rep. 2025;3:1–7. · DOI
  71. Aftab M, Mehmood F, Zhang C, Nadeem A, Dong Z, Jiang Y, et al. AI in Oncology: Transforming Cancer Detection through Machine Learning and Deep Learning Applications. arXiv; 2025. Available from: http://arxiv.org/abs/2501.15489. Cited 2025 Mar 12. · arXiv
  72. Boniolo F, Dorigatti E, Ohnmacht AJ, Saur D, Schubert B, Menden MP. Artificial intelligence in early drug discovery enabling precision medicine. Expert Opin Drug Discov. 2021;16:991–1007. · DOI
  73. Azuaje F. Artificial intelligence for precision oncology: beyond patient stratification. NPJ precision oncology. 2019;3:6. · DOI · Paper page
  74. Jie Z, Zhiying Z, Li L. A meta-analysis of Watson for Oncology in clinical application. Sci Rep. 2021;11:5792. · DOI · Paper page
  75. Klau JH, Maj C, Klinkhammer H, Krawitz PM, Mayr A, Hillmer AM, et al. AI-based multi-PRS models outperform classical single-PRS models. Front Genet. 2023;14. Available from: https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1217860/full. Cited 2025 Apr 5. · DOI
  76. Ovchinnikova K, Born J, Chouvardas P, Rapsomaniki M, Kruithof-de Julio M. Overcoming limitations in current measures of drug response may enable AI-driven precision oncology. npj Precis Onc. 2024;8:1–7. · DOI
  77. Wang Q, Berger NA, Xu R. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection. JAMA Oncol. 2021;7:220–7. · DOI · Paper page
  78. Fountzilas E, Pearce T, Baysal MA, Chakraborty A, Tsimberidou AM. Convergence of evolving artificial intelligence and machine learning techniques in precision oncology. npj Digit Med. 2025;8:1–19. · DOI · Paper page
  79. Klau JH, Maj C, Klinkhammer H, Krawitz PM, Mayr A, Hillmer AM, et al. AI-based multi-PRS models outperform classical single-PRS models. Front Genet. 2023;14:1217860. · DOI
  80. Park A, Lee Y, Nam S. A performance evaluation of drug response prediction models for individual drugs. Sci Rep. 2023;13:11911. · DOI
  81. Firoozbakht F, Yousefi B, Tsoy O, Baumbach J, Schwikowski B. Comparative evaluation of feature reduction methods for drug response prediction. Sci Rep. 2024;14:30885. · DOI
  82. Sun H, Li C, Pu Z, Lu Y, Wu Z, Zhou L, et al. Single-cell RNA sequencing and AlphaFold 3 insights into cytokine signaling and its role in uveal melanoma. Front Immunol. 2025;15:1458041. · DOI
  83. Abstract S6–07: Double blinded validation study to assess performance of IBM artificial intelligence platform, Watson for oncology in comparison with Manipal multidisciplinary tumour board – First study of 638 breast cancer cases | Cancer Research | American Association for Cancer Research. Available from: https://aacrjournals.org/cancerres/article/77/4_Supplement/S6-07/624543/Abstract-S6-07-Double-blinded-validation-study-to. Cited 2025 Mar 30. · DOI · Paper page
  84. Somashekhar SP, Kumarc R, Rauthan A, Arun KR, Patil P, Ramya YE. Abstract S6–07: Double blinded validation study to assess performance of IBM artificial intelligence platform, Watson for oncology in comparison with Manipal multidisciplinary tumour board–First study of 638 breast cancer cases. Can Res. 2017;77:S6-07. · DOI · Paper page
  85. Jin D, Khan NU, Gu W, Lei H, Goel A, Chen T. Informatics strategies for early detection and risk mitigation in pancreatic cancer patients. Neoplasia. 2025;60: 101129. · DOI
  86. Sud A, Turnbull C, Houlston R. Will polygenic risk scores for cancer ever be clinically useful? npj Precis Onc. 2021;5:1–5. · DOI
  87. Bartolomucci A, Nobrega M, Ferrier T, Dickinson K, Kaorey N, Nadeau A, et al. Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology. npj Precis Onc. 2025;9:1–19. · DOI · Paper page
  88. Connal S, Cameron JM, Sala A, Brennan PM, Palmer DS, Palmer JD, et al. Liquid biopsies: the future of cancer early detection. J Transl Med. 2023;21:118. · DOI · Paper page
  89. Yaghoubi Naei V, Bordhan P, Mirakhorli F, Khorrami M, Shrestha J, Nazari H, et al. Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA. Ther Adv Med Oncol. 2023;15:17588359231192400. · DOI
  90. Ju S, Chen C, Zhang J, Xu L, Zhang X, Li Z, et al. Detection of circulating tumor cells: opportunities and challenges. Biomark Res. 2022;10:58. · DOI · Paper page
  91. Xie X, Li Y, Lian S, Lu Y, Jia L. Cancer metastasis chemoprevention prevents circulating tumour cells from germination. Sig Transduct Target Ther. 2022;7:1–16. · DOI
  92. He Y, Pei J, Li X, Chi G. IL-35 promotes EMT through STAT3 activation and induces MET by promoting M2 macrophage polarization in HCC. Biochem Biophys Res Commun. 2021;559:35–41. · DOI
  93. Lee C-C, Lin J-C, Hwang W-L, Kuo Y-J, Chen H-K, Tai S-K, et al. Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization. Nat Commun. 2018;9:3763. · DOI · Paper page
  94. Lawrence R, Watters M, Davies CR, Pantel K, Lu Y-J. Circulating tumour cells for early detection of clinically relevant cancer. Nat Rev Clin Oncol. 2023;1–14. · DOI · Paper page
  95. Jamshidi A, Liu MC, Klein EA, Venn O, Hubbell E, Beausang JF, et al. Evaluation of cell-free DNA approaches for multi-cancer early detection. Cancer Cell. 2022;40:1537-1549.e12. · DOI · Paper page
  96. Li J, Wei L, Zhang X, Zhang W, Wang H, Zhong B, et al. DISMIR: Deep learning-based noninvasive cancer detection by integrating DNA sequence and methylation information of individual cell-free DNA reads. Briefings in Bioinformatics. 2021;22:bbab250. · DOI
  97. Wan N, Weinberg D, Liu T-Y, Niehaus K, Ariazi EA, Delubac D, et al. Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA. BMC Cancer. 2019;19:832. · DOI · Paper page
  98. Mgbole TJ. Advanced neural network systems for analysis of blood-based biomarkers in metastatic disease detection. World Journal of Advanced Research and Reviews. 2025;25:662–86. · doi:10.30574/wjarr.2025.25.1.0083
  99. Guo X, Lin F, Yi C, Song J, Sun D, Lin L, et al. Deep transfer learning enables lesion tracing of circulating tumor cells. Nat Commun. 2022;13:7687. · DOI
  100. Eledkawy A, Hamza T, El-Metwally S. Precision cancer classification using liquid biopsy and advanced machine learning techniques. Sci Rep. 2024;14:5841. · DOI
  101. Gerratana L, Davis AA, Foffano L, Reduzzi C, Rossi T, Medford A, et al. Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling. Cancer Lett. 2025;609: 217325. · DOI
  102. Turnbull C, Wald N, Sullivan R, Pharoah P, Houlston RS, Aggarwal A, et al. GRAIL-Galleri: why the special treatment? The Lancet. 2024;403:431–2. · DOI
  103. Karimzadeh M, Momen-Roknabadi A, Cavazos TB, Fang Y, Chen N-C, Multhaup M, et al. Deep generative AI models analyzing circulating orphan non-coding RNAs enable detection of early-stage lung cancer. Nat Commun. 2024;15:10090. · DOI
  104. Song Z, An M, Liu Y, Wang X, Li N, Chen X, et al. A liquid biopsy-based assay for classifying breast cancer from benign nodule. JCO. 2024;42:e12572–e12572. · doi:10.1200/jco.2024.42.16_suppl.e12572
  105. Benfatto S, Sill M, Jones DTW, Pfister SM, Sahm F, von Deimling A, et al. Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics. Nat Commun. 2025;16:1787. · DOI
  106. Naquin TD, Canning AJ, Gu Y, Chen J, Naquin CM, Xia J, et al. Acoustic separation and concentration of exosomes for nucleotide detection: ASCENDx. Science Advances. 2024;10:eadm8597. · DOI
  107. Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32:1167–77. · DOI · Paper page
  108. Filippova D, Larson MH, Maher MC, Calef R, Pimentel M, Zhou Y, et al. The Circulating Cell-free Genome Atlas (CCGA) Study: Size selection of cell-free DNA (cfDNA) fragments. JCO. 2019;37:3103–3103. · doi:10.1200/jco.2019.37.15_suppl.3103
  109. Tay JK, Narasimhan B, Hastie T. Elastic Net Regularization Paths for All Generalized Linear Models. arXiv; 2021. Available from: http://arxiv.org/abs/2103.03475. Cited 2025 Apr 5. · arXiv
  110. Huang D, Li Z, Jiang T, Yang C, Li N. Artificial intelligence in lung cancer: current applications, future perspectives, and challenges. Front Oncol. 2024;14:1486310. · DOI
  111. Viet CT, Asam KR, Yu G, Dyer EC, Kochanny S, Thomas CM, et al. Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma. npj Precis Onc. 2024;8:1–12. · DOI
  112. Dolezal JM, Kochanny S, Dyer E, Ramesh S, Srisuwananukorn A, Sacco M, et al. Slideflow: deep learning for digital histopathology with real-time whole-slide visualization. BMC Bioinformatics. 2024;25:134. · DOI
  113. Viet CT, Asam KR, Yu G, Dyer EC, Kochanny S, Thomas CM, et al. Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma. NPJ Precis Oncol. 2024;8:130. · DOI
  114. Wasilewski T, Kamysz W, Gębicki J. AI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring. Biosensors (Basel). 2024;14:356. · DOI · Paper page
  115. Talens JB, Pelegri-Sebastia J, Sogorb T, Ruiz JL. Prostate cancer detection using e-nose and AI for high probability assessment. BMC Med Inform Decis Mak. 2023;23:205. · doi:10.1186/s12911-023-02312-2
  116. Dang T, Yang J, Zang C, Ma S, Ding Y, Yoda H, et al. Label -free measuring biomolecular interactions using plasmonic metasurfaces with dual bands based on surface lattice resonances in the mid-infrared range. Sens Actuators, B Chem. 2024;417: 136230. · DOI
  117. Zhou N, Zhang C, Lv H, Hao C, Li T, Zhu J, et al. Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China. Oncologist. 2019;24:812–9. · DOI · Paper page
  118. Alum EU. AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis. Discov Oncol. 2025;16:313. · DOI
  119. Adamson B, Waskom M, Blarre A, Kelly J, Krismer K, Nemeth S, et al. Approach to machine learning for extraction of real-world data variables from electronic health records. Front Pharmacol. 2023;14:1180962. · DOI
  120. The Paige Prostate Suite: Assistive Artificial Intelligence for Prostate Cancer Diagnosis: Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024. Available from: http://www.ncbi.nlm.nih.gov/books/NBK608438/. Cited 2025 Apr 7.
  121. Lou Z, Cheng C, Mao R, Li D, Tian L, Li B, et al. A novel automated planning approach for multi-anatomical sites cancer in Raystation treatment planning system. Physica Med. 2023;109: 102586. · doi:10.1016/j.ejmp.2023.102586
  122. van de Schoot AJ, Hoffmans D, van Ingen KM, Simons MJ, Wiersma J. Characterization of Ethos therapy systems for adaptive radiation therapy: A multi-machine comparison. J Appl Clin Med Phys. 2023;24: e13905. · doi:10.1002/acm2.13905
  123. Zavaleta-Monestel E, Quesada-Villaseñor R, Arguedas-Chacón S, García-Montero J, Barrantes-López M, Salas-Segura J, et al. Revolutionizing Healthcare: Qure.AI’s Innovations in Medical Diagnosis and Treatment. Cureus. 2024;16:e61585. · DOI
  124. Kaul V, Enslin S, Gross SA. History of artificial intelligence in medicine. Gastrointest Endosc. 2020;92:807–12. · DOI · Paper page
  125. Liu C, Liu X, Wu F, Xie M, Feng Y, Hu C. Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility Study. J Med Internet Res. 2018;20: e11087. · DOI · Paper page
  126. Lee K, Lee SH. Artificial Intelligence-Driven Oncology Clinical Decision Support System for Multidisciplinary Teams. Sensors. 2020;20:4693. · doi:10.3390/s20174693
  127. Lim G, Kim H, Choi Y, Li TJ-J, Kulkarni C, Subramonyam H, et al. Designing for AI-Powered Social Computing Systems. 2023. p. 572–5. · DOI
  128. Chaudhary Z, Lungren C, Shah A. Tempus: Reshaping the Landscape of Cancer Care with Revolutionary Artificial Intelligence. Teens in Health AI in Healthcare Summer 2023 Journal Teens in Health is a teen led organization that aims to provide open access to biological research skill development through researching and writing articles This session, students spent 5 weeks working on individual articles, on all different topics of AI in Healthcare. 2023;148.
  129. Mallahan S, Gajra A, Blau S, Peguero J, Shoukier M, Kanaan M, et al. Optimizing Clinical Trial Subject Selection: Insights from Exigent Research Network and the Tempus AI TIME Program Collaboration. AI in Precision Oncology. 2024;1:306–14. · DOI
  130. Flach RN, Van Dooijeweert C, Nguyen TQ, Lynch M, Jonges TN, Meijer RP, et al. Prospective Clinical Implementation of Paige Prostate Detect Artificial Intelligence Assistance in the Detection of Prostate Cancer in Prostate Biopsies: CONFIDENT P Trial Implementation of Artificial Intelligence Assistance in Prostate Cancer Detection. JCO Clin Cancer Inform. 2025;e2400193. · DOI
  131. Eloy C, Marques A, Pinto J, Pinheiro J, Campelos S, Curado M, et al. Artificial intelligence–assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies. Virchows Arch. 2023;482:595–604. · DOI
  132. Huanbutta K, Burapapadh K, Kraisit P, Sriamornsak P, Ganokratanaa T, Suwanpitak K, et al. Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. Eur J Pharm Sci. 2024;203: 106938. · DOI
  133. Chan SPY, Yeo CPX, Yeo ELL, Poon DJJ, Chu PL, Chua MLK, et al. A Quadratic Phenotypic Optimization Drug Screening Platform (QPOP) Identified Chromatin Modification as a Potential Strategy to Target Radioresistant (RR) Head and Neck Cancers (HNC). International Journal of Radiation Oncology*Biology*Physics. 2022;114:S11–2. · doi:10.1016/j.ijrobp.2022.07.350
  134. Yang Z, Zeng X, Zhao Y, Chen R. AlphaFold2 and its applications in the fields of biology and medicine. Signal Transduct Target Ther. 2023;8:115. · DOI · Paper page
  135. Guha R, Velegol D. Harnessing Shannon entropy-based descriptors in machine learning models to enhance the prediction accuracy of molecular properties. J Cheminform. 2023;15:54. · doi:10.1186/s13321-023-00712-0
  136. Wang J, Liu X, Shen S, Deng L, Liu H. DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations. Briefings in Bioinformatics. 2022;23:bbab390. · DOI · Paper page
  137. Abbas MKG, Rassam A, Karamshahi F, Abunora R, Abouseada M. The Role of AI in Drug Discovery. ChemBioChem. 2024;25: e202300816. · DOI
  138. Putin E, Asadulaev A, Ivanenkov Y, Aladinskiy V, Sanchez-Lengeling B, Aspuru-Guzik A, et al. Reinforced Adversarial Neural Computer for de Novo Molecular Design. J Chem Inf Model. 2018;58:1194–204. · DOI · Paper page
  139. Ramesh P, Karuppasamy R, Veerappapillai S. Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer. Med Oncol. 2022;40:56. · DOI
  140. Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 2016;44:D1045–53. · DOI · Paper page
  141. Yap CW. PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. J Comput Chem. 2011;32:1466–74. · DOI · Paper page
  142. Mangione W, Samudrala R. Identifying protein features responsible for improved drug repurposing accuracies using the CANDO platform: Implications for drug design. Molecules. 2019;24:167. · DOI
  143. Chopra G, Samudrala R. Exploring polypharmacology in drug discovery and repurposing using the CANDO platform. Curr Pharm Des. 2016;22:3109–23. · DOI
  144. Wu K, Xia Y, Deng P, Liu R, Zhang Y, Guo H, et al. TamGen: drug design with target-aware molecule generation through a chemical language model. Nat Commun. 2024;15:9360. · DOI
  145. Wallach I, Bernard D, Nguyen K, Ho G, Morrison A, Stecula A, et al. AI is a viable alternative to high throughput screening: a 318-target study. Sci Rep. 2024;14:7526. · DOI
  146. Wang Y, Guo M, Chen X, Ai D. Screening of multi deep learning-based de novo molecular generation models and their application for specific target molecular generation. Sci Rep. 2025;15:4419. · DOI
  147. Bagal V, Aggarwal R, Vinod PK, Priyakumar UD. MolGPT: Molecular Generation Using a Transformer-Decoder Model. J Chem Inf Model. 2022;62:2064–76. · DOI · Paper page
  148. Wang J, Liu X, Shen S, Deng L, Liu* H. DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations. arXiv; 2021. Available from: http://arxiv.org/abs/2107.02467. Cited 2025 Apr 5. · arXiv · doi:10.1101/2021.04.06.438723
  149. Duo L, Liu ,Yu, Ren ,Jianfeng, Tang ,Bencan, and Hirst JD. Artificial intelligence for small molecule anticancer drug discovery. Expert Opinion on Drug Discovery. 2024;19:933–48. · DOI
  150. Popova M, Isayev O, Tropsha A. Deep reinforcement learning for de novo drug design. Sci Adv. 2018;4:eaap7885. · DOI · Paper page
  151. Khemchandani Y, O’Hagan S, Samanta S, Swainston N, Roberts TJ, Bollegala D, et al. DeepGraphMolGen, a multi-objective, computational strategy for generating molecules with desirable properties: a graph convolution and reinforcement learning approach. J Cheminform. 2020;12:53. · DOI · Paper page
  152. You J, Liu B, Ying R, Pande V, Leskovec J. Graph convolutional policy network for goal-directed molecular graph generation. Proceedings of the 32nd International Conference on Neural Information Processing Systems. Red Hook, NY, USA: Curran Associates Inc.; 2018. p. 6412–22.
  153. Tiwari A, Saudarshan H, Krisnawati DI, Khafid M, Wardani E, Mutalik C, et al. Generating Lymphoma Variability Through Adversarial Generation Models: A Limited Resource Approach for Synthetic Histopathology Image Generation and Classification. Rochester, NY: Social Science Research Network; 2024. Available from: https://papers.ssrn.com/abstract=4995789. Cited 2025 Apr 21. · doi:10.2139/ssrn.4995789
  154. Li Y, Liu Y, Wu J, Liu X, Wang L, Wang J, et al. Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Inhibitors of CDK8 for the Treatment of Cancer. J Med Chem. 2023;66:5439–52. · DOI
  155. Hawkins MA, Brooks C, Hansen VN, Aitken A, Tait DM. Cone beam computed tomography–derived adaptive radiotherapy for radical treatment of esophageal cancer. International Journal of Radiation Oncology* Biology* Physics. 2010;77:378–83. · doi:10.1016/j.ijrobp.2009.05.045
  156. Ward A, Graham S, Almond E, Withers D. CBCT (Cone-Beam CT)-Based Online Adaptive Radiotherapy in the Post-operative Oesophageal Cancer Patient. Cureus. 2024;16. Available from: https://www.cureus.com/articles/281515-cbct-cone-beam-ct-based-online-adaptive-radiotherapy-in-the-post-operative-oesophageal-cancer-patient.pdf. Cited 2025 Apr 13. · doi:10.7759/cureus.70971
  157. Zhou X-Y, Guo Y, Shen M, Yang G-Z. Application of artificial intelligence in surgery. Frontiers of medicine. 2020;14:417–30. · DOI · Paper page
  158. Li Y, Jaarsveld R van, Jong R de, Bongers J, Kuiper G, Hillegersberg R van, et al. Benchmarking and Enhancing Surgical Phase Recognition Models for Robotic-Assisted Esophagectomy. arXiv; 2024. Available from: http://arxiv.org/abs/2412.04039. Cited 2025 Apr 21. · DOI
  159. Wang J, Zeng Z, Li Z, Liu G, Zhang S, Luo C, et al. The clinical application of artificial intelligence in cancer precision treatment. J Transl Med. 2025;23:120. · DOI
  160. Sendín-Martín M, Lara-Caro M, Harris U, Moronta M, Rossi A, Lee E, et al. Classification of basal cell carcinoma in ex vivo confocal microscopy images from freshly excised tissues using a deep learning algorithm. J Investig Dermatol. 2022;142:1291–9. · DOI
  161. Fan JL, Nazaret A, Azizi E. A thousand and one tumors: the promise of AI for cancer biology. nature methods. 2024;21:1403–6. · DOI
  162. Valente DS, Brasil LJ, de Freitas Spinelli L, Vilela MAP, Rhoden EL. A narrative review of transforming surgical education with artificial intelligence: opportunities and challenges. AME Surgical Journal. 2025;5. Available from: https://asj.amegroups.org/article/view/97081/html. Cited 2025 Apr 15. · doi:10.21037/asj-24-25
  163. Atkinson CJ, Seth I, Seifman MA, Rozen WM, Cuomo R. Enhancing hand fracture care: a prospective study of artificial intelligence application with ChatGPT. Journal of Hand Surgery Global Online. 2024;6:524–8. · DOI
  164. Vandewinckele L, Claessens M, Dinkla A, Brouwer C, Crijns W, Verellen D, et al. Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance. Radiother Oncol. 2020;153:55–66. · DOI · Paper page
  165. Lustberg T, van Soest J, Jochems A, Deist T, van Wijk Y, Walsh S, et al. Big data in radiation therapy: challenges and opportunities. Br J Radiol. 2017;90:20160689. · DOI
  166. Rong Y, Rosu-Bubulac M, Benedict SH, Cui Y, Ruo R, Connell T, et al. Rigid and Deformable Image Registration for Radiation Therapy: A Self-Study Evaluation Guide for NRG Oncology Clinical Trial Participation. Pract Radiat Oncol. 2021;11:282–98. · DOI
  167. Ershad M, Rege R, Majewicz FA. Automatic and near real-time stylistic behavior assessment in robotic surgery. Int J Comput Assist Radiol Surg. 2019;14:635–43. · DOI
  168. Ward A, Graham S, Almond E, Withers D. CBCT (Cone-Beam CT)-Based Online Adaptive Radiotherapy in the Post-operative Oesophageal Cancer Patient. Cureus. 2024;16: e70971.
  169. Najafi H, Savoji K, Mirzaeibonehkhater M, Moravvej SV, Alizadehsani R, Pedrammehr S. A Novel Method for 3D Lung Tumor Reconstruction Using Generative Models. Diagnostics (Basel). 2024;14:2604. · doi:10.3390/diagnostics14222604
  170. Wu S, Tang M, Liu J, Qin D, Wang Y, Zhai S, et al. Impact of an AI-based laparoscopic cholecystectomy coaching program on the surgical performance: a randomized controlled trial. Int J Surg. 2024;110:7816–23. · DOI
  171. Sun L-W, Van Meer F, Bailly Y, Yeung CK. Design and Development of a Da Vinci Surgical System Simulator. 2007 International Conference on Mechatronics and Automation. 2007. p. 1050–5. Available from: https://ieeexplore.ieee.org/document/4303693. Cited 2025 Apr 7. · doi:10.1109/icma.2007.4303693
  172. Zhou Q, Huang J, Pan F, Li J, Liu Y, Hou Y, et al. Operative outcomes and long-term survival of robotic-assisted segmentectomy for stage IA lung cancer compared with video-assisted thoracoscopic segmentectomy. Transl Lung Cancer Res. 2020;9:306–15. · doi:10.21037/tlcr-20-533
  173. Valente DS, Brasil LJ, de Freitas Spinelli L, Vilela MAP, Rhoden EL. A narrative review of transforming surgical education with artificial intelligence: opportunities and challenges. AME Surgical Journal. 2025;5. Available from: https://asj.amegroups.org/article/view/97081/html. Cited 2025 Mar 31. · doi:10.21037/asj-24-25
  174. Teh BS, Woo SY, Butler EB. Intensity Modulated Radiation Therapy (IMRT): A New Promising Technology in Radiation Oncology. Oncologist. 1999;4:433–42. · doi:10.1634/theoncologist.4-6-433
  175. Ji Y, Huang T, Wu Y, Li R, Wang P, Dong J, et al. Real-time ultrasound AR 3D visualization toward better topological structure perception for hepatobiliary surgery. Int J Comput Assist Radiol Surg. 2025;20:613–23. · doi:10.1007/s11548-024-03273-1
  176. Di Mitri M, Di Carmine A, D’Antonio S, Capobianco BM, Bisanti C, Collautti E, et al. Advancing Pediatric Surgery: The Use of HoloLens 2 for 3D Anatomical Reconstructions in Preoperative Planning. Children. 2025;12:32. · doi:10.3390/children12010032
  177. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869–74. · DOI · Paper page
  178. Cardoso F, Van’T Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. N Engl J Med. 2016;375:717–29. · DOI · Paper page
  179. Group EBCTC. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. The Lancet. 2012;379:432–44. · DOI · Paper page
  180. Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, et al. Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction. Cell. 2019;178:699–713. · DOI · Paper page
  181. Avanzo M, Wei L, Stancanello J, Vallières M, Rao A, Morin O, et al. Machine and deep learning methods for radiomics. Medical Physics. 2020;47. Available from: https://aapm.onlinelibrary.wiley.com/doi/10.1002/mp.13678 . Cited 2025 Apr 15. · DOI · Paper page
  182. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, Van Stiphout RG, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441–6. · DOI · Paper page
  183. Bakshi B, Dadhania S, Holloway P, Corbett C, Payling M. Using an artificial intelligence platform to enhance cancer detection rates in primary care. JCO. 2024;42:1560–1560. · doi:10.1200/jco.2024.42.16_suppl.1560
  184. Sarker IH. Deep Learning: A Comprehensive Overview on Techniques, Taxonomy, Applications and Research Directions. SN Comput Sci. 2021;2:420. · DOI · Paper page
  185. Wu B-R, Ormazabal Arriagada S, Hsu T-C, Lin T-W, Lin C. Exploiting common patterns in diverse cancer types via multi-task learning. NPJ Precis Oncol. 2024;8:245. · DOI
  186. Cai Z, Poulos RC, Liu J, Zhong Q. Machine learning for multi-omics data integration in cancer. iScience. 2022;25:103798. · DOI · Paper page
  187. Yao G, Zhang N, Duan Z, Tian C. Improved SARSA and DQN algorithms for reinforcement learning. Theoret Comput Sci. 2025;1027: 115025. · DOI
  188. Mohammed MA, Lakhan A, Abdulkareem KH, Deveci M, Dutta AK, Memon S, et al. Federated-Reinforcement Learning-Assisted IoT Consumers System for Kidney Disease Images. IEEE Trans Consum Electron. 2024;70:7163–73. · DOI
  189. Quazi S. Artificial intelligence and machine learning in precision and genomic medicine. Med Oncol. 2022;39:120. · DOI · Paper page
  190. Deepali, Goel N, Padmavati Khandnor. Advances in AI-based genomic data analysis for cancer survival prediction. Multimed Tools Appl. 2024; Available from: https://doi.org/10.1007/s11042-024-19684-w. Cited 2025 Mar 12. · DOI
  191. Hazra S, Bora KS. Capitalization of digital healthcare: The cornerstone of emerging medical practices. Intelligent Pharmacy. 2025; Available from: https://www.sciencedirect.com/science/article/pii/S2949866X24001229. Cited 2025 Apr 7. · DOI
  192. Thacharodi A, Singh P, Meenatchi R, Tawfeeq Ahmed ZH, Kumar RRS, V N, et al. Revolutionizing healthcare and medicine: The impact of modern technologies for a healthier future—A comprehensive review. Health Care Science. 2024;3:329–49. · DOI · Paper page
  193. Liao J, Li X, Gan Y, Han S, Rong P, Wang W, et al. Artificial intelligence assists precision medicine in cancer treatment. Front Oncol. 2023;12: 998222. · DOI · Paper page
  194. Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Sig Transduct Target Ther. 2024;9:1–36. · DOI · Paper page
  195. Chen Y-M, Hsiao T-H, Lin C-H, Fann YC. Unlocking precision medicine: clinical applications of integrating health records, genetics, and immunology through artificial intelligence. J Biomed Sci. 2025;32:16. · DOI
  196. Borkar S, Chakole S, Prasad R, Bansod S. Revolutionizing Oncology: A Comprehensive Review of Digital Health Applications. Cureus. 2024;16. Available from: https://www.cureus.com/articles/199122-revolutionizing-oncology-a-comprehensive-review-of-digital-health-applications.pdf. Cited 2025 Mar 16. · DOI
  197. Cardoso F, Veer LJ van’t, Bogaerts J, Slaets L, Viale G, Delaloge S, et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. New England Journal of Medicine. 2016;375:717–29. · DOI · Paper page
  198. Zengin N, Kars A, Kansu E, Özdemir O, Barişta İ, Güllü İ, et al. Comparison of Rai and Binet Classifications in Chronic Lymphocytic Leukemia. Hematology. 1997;2:125–9. · doi:10.1080/10245332.1997.11746327
  199. Al-Sawaf O, Esfahani MS, Zhang C, Tausch E, Schilhabel A, Eichhorst B, et al. A Continuous Individualized Risk Index for Refined Outcome Prediction After Targeted Therapy for Patients with Chronic Lymphocytic Leukemia (ciri-Cll). Hematological Oncology. 2021;39. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/hon.51_2880. Cited 2025 Mar 31. · doi:10.1002/hon.51_2880
  200. Olawade DB, David-Olawade AC, Wada OZ, Asaolu AJ, Adereni T, Ling J. Artificial intelligence in healthcare delivery: Prospects and pitfalls. J Med Surg Public Health. 2024;3: 100108. · DOI · Paper page

200 of 204 shown

Cited by

See all 207

Metadata

Authors
Tiwari, A., Mishra, S., & Kuo, T.-R.
Venue
Molecular Cancer
Published
2025-06-02
Volume
24
Issue
1
Pages
159-159
ISSN
1476-4598 (ISSN-L)
OpenAlex
W4410939981
Cited by
207
References
62
FWCI
86.14
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • National Science and Technology Council (NSTC 113-2113-M-038-001)
  • Taipei Medical University

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current AI technologies in cancer diagnostics and treatment. https://app.cochat.ai/papers/10.1186/s12943-025-02369-9
The paper
Tiwari, A., Mishra, S., & Kuo, T.-R. (2025). Current AI technologies in cancer diagnostics and treatment. Molecular Cancer. https://doi.org/10.1186/s12943-025-02369-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.